Legal Cannabis Market Size, Share and Growth Outlook 2026: By Application (Medical Use, Recreational Use, Industrial Use), By Product Type, By Compound, By Source, By Distribution Channel, Companies to 2034.
The global Legal Cannabis Market size is forecast to increase from $83.91 Billion in 2026 to $225.29 Billion in 2034 at a CAGR of 13.14% between 2026 and 2034.
The Legal Cannabis market report provides detailed analysis and outlook of Legal Cannabis segments including By Application (Medical Use, Recreational Use, Industrial Use), By Product Type (Flower Buds, Oils and Tinctures, Other Products), By Compound (THC-Dominant, CBD-Dominant, Balanced THC and CBD), By Source (Marijuana, Hemp), By Distribution Channel (Recreational Stores, Pharmacies, Online Stores, Other Distribution Channels) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Legal Cannabis Industry Overview
Regulatory Reclassification Reshapes the Legal Cannabis Landscape
The legal cannabis industry is undergoing a significant regulatory transition as federal authorities reassess the treatment of cannabis within the United States regulatory framework. A major milestone was reached when the U.S. Department of Justice and the Drug Enforcement Administration issued a final order moving FDA-approved marijuana products and marijuana products operating under qualifying state-issued medical licenses from Schedule I to Schedule III under the Controlled Substances Act. This change recognizes the growing role of regulated medical cannabis programs and is expected to facilitate broader scientific research, improve regulatory clarity, and expand opportunities for pharmaceutical and healthcare stakeholders involved in cannabinoid-based therapies. The development marks one of the most consequential regulatory shifts affecting the cannabis sector in recent years.
Federal Review Expands Focus on Medical Research and Market Access
The industry continues to closely monitor ongoing federal proceedings that could further redefine cannabis regulation. Following the reclassification order, the DEA initiated an administrative hearing process to evaluate evidence regarding the broader placement of marijuana within Schedule III. This review reflects increasing policy attention toward balancing public health considerations, medical access, scientific evidence, and commercial regulation. Greater research accessibility remains a central industry objective, as stakeholders seek expanded opportunities to investigate therapeutic applications, product standardization, clinical efficacy, and safety profiles. The evolving federal framework is encouraging healthcare providers, researchers, and cannabis companies to prepare for a more structured and research-oriented operating environment.
State-Level Policies Continue to Create Market Complexity
Despite progress at the federal level, the legal cannabis industry remains highly fragmented due to varying state-level regulations. Several jurisdictions have pursued measures aimed at restricting or modifying existing cannabis frameworks even where legalization has already been established. Ohio’s Senate Bill 56 introduced new limitations related to THC concentrations, public consumption, and home cultivation, illustrating the ongoing policy divergence across the United States. This dynamic regulatory environment continues to influence product development, compliance strategies, distribution models, and investment decisions. As cannabis markets mature, companies must navigate a complex landscape shaped by both expanding federal recognition and evolving state-specific regulatory requirements.
Legal Cannabis Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Legal Cannabis market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Curaleaf Holdings, Inc., Green Thumb Industries (GTI), Trulieve Cannabis Corp., Cresco Labs Inc., Tilray Brands, Inc., Canopy Growth Corporation, Aurora Cannabis Inc., Verano Holdings Corp., Cronos Group Inc., Jazz Pharmaceuticals plc (GW Pharmaceuticals portfolio). The Legal Cannabis market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Legal Cannabis industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
Leading companies in Legal Cannabis industry include- Curaleaf Holdings, Inc., Green Thumb Industries (GTI), Trulieve Cannabis Corp., Cresco Labs Inc., Tilray Brands, Inc., Canopy Growth Corporation, Aurora Cannabis Inc., Verano Holdings Corp., Cronos Group Inc., Jazz Pharmaceuticals plc (GW Pharmaceuticals portfolio). The Legal Cannabis market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Legal Cannabis Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Legal Cannabis market remains one of the strongest-performing segments in the country.
The US Legal Cannabis Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Legal Cannabis market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Legal Cannabis industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Legal Cannabis markets
Canada's strong Legal Cannabis sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Legal Cannabis market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Legal Cannabis Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Legal Cannabis market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Legal Cannabis population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Legal Cannabis industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Legal Cannabis market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Legal Cannabis sales through 2034
France Legal Cannabis companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Legal Cannabis Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Legal Cannabis distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Legal Cannabis Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Legal Cannabis market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Legal Cannabis industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Legal Cannabis industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Legal Cannabis Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Legal Cannabis market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Legal Cannabis market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Legal Cannabis Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Legal Cannabis Market Segmentation
By Application
Medical Use
Recreational Use
Industrial Use
By Product Type
Flower Buds
Oils and Tinctures
Other Products
By Compound
THC-Dominant
CBD-Dominant
Balanced THC and CBD
By Source
Marijuana
Hemp
By Distribution Channel
Recreational Stores
Pharmacies
Online Stores
Other Distribution Channels
Leading Companies in Legal Cannabis Industry (2026)
Curaleaf Holdings, Inc.
Green Thumb Industries (GTI)
Trulieve Cannabis Corp.
Cresco Labs Inc.
Tilray Brands, Inc.
Canopy Growth Corporation
Aurora Cannabis Inc.
Verano Holdings Corp.
Cronos Group Inc.
Jazz Pharmaceuticals plc (GW Pharmaceuticals portfolio)
Countries Included
The Legal Cannabis market report provides detailed analysis and outlook of Legal Cannabis segments including By Application (Medical Use, Recreational Use, Industrial Use), By Product Type (Flower Buds, Oils and Tinctures, Other Products), By Compound (THC-Dominant, CBD-Dominant, Balanced THC and CBD), By Source (Marijuana, Hemp), By Distribution Channel (Recreational Stores, Pharmacies, Online Stores, Other Distribution Channels) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.
Legal Cannabis Industry Overview
Regulatory Reclassification Reshapes the Legal Cannabis Landscape
The legal cannabis industry is undergoing a significant regulatory transition as federal authorities reassess the treatment of cannabis within the United States regulatory framework. A major milestone was reached when the U.S. Department of Justice and the Drug Enforcement Administration issued a final order moving FDA-approved marijuana products and marijuana products operating under qualifying state-issued medical licenses from Schedule I to Schedule III under the Controlled Substances Act. This change recognizes the growing role of regulated medical cannabis programs and is expected to facilitate broader scientific research, improve regulatory clarity, and expand opportunities for pharmaceutical and healthcare stakeholders involved in cannabinoid-based therapies. The development marks one of the most consequential regulatory shifts affecting the cannabis sector in recent years.
Federal Review Expands Focus on Medical Research and Market Access
The industry continues to closely monitor ongoing federal proceedings that could further redefine cannabis regulation. Following the reclassification order, the DEA initiated an administrative hearing process to evaluate evidence regarding the broader placement of marijuana within Schedule III. This review reflects increasing policy attention toward balancing public health considerations, medical access, scientific evidence, and commercial regulation. Greater research accessibility remains a central industry objective, as stakeholders seek expanded opportunities to investigate therapeutic applications, product standardization, clinical efficacy, and safety profiles. The evolving federal framework is encouraging healthcare providers, researchers, and cannabis companies to prepare for a more structured and research-oriented operating environment.
State-Level Policies Continue to Create Market Complexity
Despite progress at the federal level, the legal cannabis industry remains highly fragmented due to varying state-level regulations. Several jurisdictions have pursued measures aimed at restricting or modifying existing cannabis frameworks even where legalization has already been established. Ohio’s Senate Bill 56 introduced new limitations related to THC concentrations, public consumption, and home cultivation, illustrating the ongoing policy divergence across the United States. This dynamic regulatory environment continues to influence product development, compliance strategies, distribution models, and investment decisions. As cannabis markets mature, companies must navigate a complex landscape shaped by both expanding federal recognition and evolving state-specific regulatory requirements.
Legal Cannabis Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities
The global Legal Cannabis market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- Curaleaf Holdings, Inc., Green Thumb Industries (GTI), Trulieve Cannabis Corp., Cresco Labs Inc., Tilray Brands, Inc., Canopy Growth Corporation, Aurora Cannabis Inc., Verano Holdings Corp., Cronos Group Inc., Jazz Pharmaceuticals plc (GW Pharmaceuticals portfolio). The Legal Cannabis market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Legal Cannabis industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-
- Growth Legal Cannabis Market size outlook across 3 scenarios- High growth, reference, and Low growth cases
- Market Trends, Drivers, Potential Opportunities, and Challenges faced by Legal Cannabis companies
- Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry
- Detailed SWOT Analysis of global and regional Legal Cannabis markets
- Competitive analysis including business description, product analysis, and financial profiles
- Key country specific analysis detailing key factors shaping the short-term and long-term outlook
- Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements
Leading companies in Legal Cannabis industry include- Curaleaf Holdings, Inc., Green Thumb Industries (GTI), Trulieve Cannabis Corp., Cresco Labs Inc., Tilray Brands, Inc., Canopy Growth Corporation, Aurora Cannabis Inc., Verano Holdings Corp., Cronos Group Inc., Jazz Pharmaceuticals plc (GW Pharmaceuticals portfolio). The Legal Cannabis market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.
What to expect in US Legal Cannabis Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034
The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Legal Cannabis market remains one of the strongest-performing segments in the country.
The US Legal Cannabis Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Legal Cannabis market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Legal Cannabis industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.
Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Legal Cannabis markets
Canada's strong Legal Cannabis sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Legal Cannabis market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.
Germany Legal Cannabis Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.
Germany continues to remain the largest Legal Cannabis market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Legal Cannabis population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Legal Cannabis industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Legal Cannabis market outlook.
France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Legal Cannabis sales through 2034
France Legal Cannabis companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.
UK Legal Cannabis Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain
Small high-need consumer segments remain key priority of Legal Cannabis distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or ?280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was ?49 billion (14.1%) and voluntary health insurance was ?9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.
China Legal Cannabis Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years
China Legal Cannabis market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Legal Cannabis industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Legal Cannabis industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.
India Legal Cannabis Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India
Indian Legal Cannabis market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.
Brazil Legal Cannabis market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities
Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.
Middle East and Africa Legal Cannabis Industry Trends and Perspectives to 2034
According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.
Legal Cannabis Market Segmentation
By Application
Medical Use
Recreational Use
Industrial Use
By Product Type
Flower Buds
Oils and Tinctures
Other Products
By Compound
THC-Dominant
CBD-Dominant
Balanced THC and CBD
By Source
Marijuana
Hemp
By Distribution Channel
Recreational Stores
Pharmacies
Online Stores
Other Distribution Channels
Leading Companies in Legal Cannabis Industry (2026)
Curaleaf Holdings, Inc.
Green Thumb Industries (GTI)
Trulieve Cannabis Corp.
Cresco Labs Inc.
Tilray Brands, Inc.
Canopy Growth Corporation
Aurora Cannabis Inc.
Verano Holdings Corp.
Cronos Group Inc.
Jazz Pharmaceuticals plc (GW Pharmaceuticals portfolio)
Countries Included
- North America- US, Canada, Mexico
- Europe- Germany, France, UK, Spain, Italy, Nordics, Others
- Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others
- Latin America- Brazil, Argentina, Others
- Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa
- Get Free print authentication across single, multi, and global licenses
- Free Accompanying excel spreadsheet with complete quantitative data
- Free 2-day consulting support from the lead analyst of the team that developed the report
- Gain clear understanding of current market conditions across 20 countries and plan your decisions accordingly
- Understand competitive profiles of the leading 15 companies in the Electrosurgical Generators industry
- Stay ahead of competition through a detailed analysis of recent market developments
- Make trusted decisions building on our 10-year experience in developing reports on Electrosurgical Generators industry
CHAPTER 1- EXECUTIVE SUMMARY
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Legal Cannabis Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Legal Cannabis Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL LEGAL CANNABIS MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Legal Cannabis Markets in 2026
3.2. Global Historic and Forecast Legal Cannabis Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Legal Cannabis Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Legal Cannabis Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Legal Cannabis Value Chain
CHAPTER 4- LEGAL CANNABIS MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Legal Cannabis Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- LEGAL CANNABIS MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Application
Medical Use
Recreational Use
Industrial Use
By Product Type
Flower Buds
Oils and Tinctures
Other Products
By Compound
THC-Dominant
CBD-Dominant
Balanced THC and CBD
By Source
Marijuana
Hemp
By Distribution Channel
Recreational Stores
Pharmacies
Online Stores
Other Distribution Channels
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA LEGAL CANNABIS MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Legal Cannabis Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Legal Cannabis Market Trends and Growth Opportunities to 2034
7.5. North America Legal Cannabis Market Size Outlook by Type
7.6. North America Legal Cannabis Market Size Outlook by Application
7.7. North America Legal Cannabis Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Legal Cannabis Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Legal Cannabis Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Legal Cannabis Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Legal Cannabis Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Legal Cannabis Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Legal Cannabis Companies
CHAPTER 8- EUROPE LEGAL CANNABIS MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Legal Cannabis Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Legal Cannabis Market Trends and Growth Opportunities to 2034
8.5. Europe Legal Cannabis Market Size Outlook by Type
8.6. Europe Legal Cannabis Market Size Outlook by Application
8.7. Europe Legal Cannabis Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Legal Cannabis Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Legal Cannabis Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Legal Cannabis Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Legal Cannabis Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Legal Cannabis Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Legal Cannabis Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Legal Cannabis Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Legal Cannabis Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Legal Cannabis Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Legal Cannabis Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Legal Cannabis Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Legal Cannabis Companies
CHAPTER 9- ASIA PACIFIC LEGAL CANNABIS MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Legal Cannabis Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Legal Cannabis Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Legal Cannabis Market Size Outlook by Type
9.6. Asia Pacific Legal Cannabis Market Size Outlook by Application
9.7. Asia Pacific Legal Cannabis Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Legal Cannabis Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Legal Cannabis Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Legal Cannabis Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Legal Cannabis Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Legal Cannabis Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Legal Cannabis Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Legal Cannabis Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Legal Cannabis Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Legal Cannabis Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Legal Cannabis Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Legal Cannabis Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Legal Cannabis Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA LEGAL CANNABIS MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Legal Cannabis Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Legal Cannabis Market Trends and Growth Opportunities to 2034
10.5. South and Central America Legal Cannabis Market Size Outlook by Type
10.6. South and Central America Legal Cannabis Market Size Outlook by Application
10.7. South and Central America Legal Cannabis Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Legal Cannabis Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Legal Cannabis Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Legal Cannabis Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Legal Cannabis Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Legal Cannabis Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Legal Cannabis Companies
CHAPTER 11- MIDDLE EAST AND AFRICA LEGAL CANNABIS MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Legal Cannabis Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Legal Cannabis Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Legal Cannabis Market Size Outlook by Type
11.6. Middle East and Africa Legal Cannabis Market Size Outlook by Application
11.7. Middle East and Africa Legal Cannabis Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Legal Cannabis Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Legal Cannabis Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Legal Cannabis Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Legal Cannabis Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Legal Cannabis Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Legal Cannabis Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Legal Cannabis Industry
Curaleaf Holdings, Inc.
Green Thumb Industries (GTI)
Trulieve Cannabis Corp.
Cresco Labs Inc.
Tilray Brands, Inc.
Canopy Growth Corporation
Aurora Cannabis Inc.
Verano Holdings Corp.
Cronos Group Inc.
Jazz Pharmaceuticals plc (GW Pharmaceuticals portfolio)
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
1.1. Market Snapshot: Market Size, CAGR, and Growth Outlook to 2034
1.2. Key Industry Highlights, 2026
1.3. Premium Market Insights
1.3.1. Potential Legal Cannabis Market Types and Applications
1.3.2. Fastest Growing Countries Over the forecast period
1.4. Market Scope and Segmentation
1.4.1. Key Market Segments
1.4.2. Key Countries and Regions
1.4.3. Top Companies in the Legal Cannabis Industry
1.5. Macroeconomic and Demographic Outlook
1.5.1. GDP Outlook by Top 20 Countries, 2010- 2040
1.5.2. Population Forecast by Country, 2010- 2040
1.5.3. Inflation Trends in Leading Countries
1.6. Impact of Trade Policies, Regulations, and Sustainability
1.6.1. Trade tariffs and localization requirements
1.6.2. ESG and sustainability pressures
1.6.3. Compliance-driven structural changes in the value chain
CHAPTER 2- RESEARCH METHODOLOGY
2.1. Report Coverage
2.2. Secondary Research
2.3. Primary Research
2.4. Data Triangulation
2.5. Market Modeling and Forecasting
CHAPTER 3- GLOBAL LEGAL CANNABIS MARKET TRENDS, GROWTH DRIVERS, CHALLENGES, AND OPPORTUNITIES THROUGH 2034
3.1. An Introduction to Global Legal Cannabis Markets in 2026
3.2. Global Historic and Forecast Legal Cannabis Market Size Outlook, USD Million, 2021- 2034
3.3. Annual Market Size Growth Rate (Y-o-Y), %, 2021-2034
3.4. Market Dynamics
3.4.1. Key Legal Cannabis Market Driving Forces and Their Impact on Market Outlook
3.4.2. Short and Long-Term Trends and Insights Shaping the Future
3.4.3. Potential Legal Cannabis Market Opportunities for Industry Stakeholders
3.4.4. Potential Challenges across Legal Cannabis Value Chain
CHAPTER 4- LEGAL CANNABIS MARKET COMPETITIVE LANDSCAPE, STRATEGIC ANALYSIS, AND VALUE CHAIN ASSESSMENT
4.1. Porter’s Five Forces Analysis
4.1.1. Bargaining Power of Buyers
4.1.2. Bargaining Power of Suppliers
4.1.3. Threat of Substitutes
4.1.4. Threat of New Entrants
4.1.5. Intensity of Competitive Rivalry
4.1.6. Market Attractiveness Analysis by Segment
4.1.7. Market Attractiveness Analysis by Region
4.2. Competitive Landscape
4.2.1 Market Share Analysis of Leading Legal Cannabis Companies
4.2.2 Recent Strategic Developments
4.2.3 Mergers, Acquisitions, and Partnerships
4.2.4 Product Launches and Innovation Trends
4.2.5 Key Success Factors
4.3. Value Chain Analysis
4.3.1. Key Value Chain Segments
4.3.2. Dominant players by value-chain stage
4.4. SWOT Analysis
4.4.1. Key Strengths and Opportunities
4.4.2. Major Weaknesses and Threats
4.5 Technology Roadmap
4.6 Regulatory and Reimbursement Landscape
CHAPTER 5- LEGAL CANNABIS MARKET OUTLOOK BY SEGMENTS
5.1. Market Size Outlook by Type, USD Million, 2021- 2025 and 2026-2034
5.2. Market Size Outlook by Application, USD Million, 2021- 2025 and 2026-2034
5.3. Market Size Outlook by Country, USD Million, 2021- 2025 and 2026-2034
By Application
Medical Use
Recreational Use
Industrial Use
By Product Type
Flower Buds
Oils and Tinctures
Other Products
By Compound
THC-Dominant
CBD-Dominant
Balanced THC and CBD
By Source
Marijuana
Hemp
By Distribution Channel
Recreational Stores
Pharmacies
Online Stores
Other Distribution Channels
CHAPTER 6- SCENARIO ANALYSIS AND OUTLOOK
6.1. Base Case Scenario
6.1.1. Definitions and Insights
6.1.2. Market Size Outlook to 2034
6.2. Low Growth Case Scenario
6.2.1. Definitions and Insights
6.2.2. Market Size Outlook to 2034
6.3. High Growth Case Scenario
6.3.1. Definitions and Insights
6.3.2. Market Size Outlook to 2034
CHAPTER 7- NORTH AMERICA LEGAL CANNABIS MARKET SIZE ANALYSIS AND OUTLOOK
7.1. North America Legal Cannabis Market Overview, 2026
7.2. Leading Companies Operating in North America
7.3. Key Industry Statistics, 2026
7.4. North America Legal Cannabis Market Trends and Growth Opportunities to 2034
7.5. North America Legal Cannabis Market Size Outlook by Type
7.6. North America Legal Cannabis Market Size Outlook by Application
7.7. North America Legal Cannabis Market Size Outlook by Country
7.8. United States
7.8.1. Key Statistics
7.8.2. The US Legal Cannabis Market Size Outlook, 2021- 2034
7.8.3. Key Market Drivers and Industry Developments in the US Legal Cannabis Companies
7.9. Canada
7.9.1. Key Statistics
7.9.2. Canada Legal Cannabis Market Size Outlook, 2021- 2034
7.9.3. Key Market Drivers and Industry Developments in Canada Legal Cannabis Companies
7.10. Mexico
7.10.1. Key Statistics
7.10.2. Mexico Legal Cannabis Market Size Outlook, 2021- 2034
7.10.3. Key Market Drivers and Industry Developments in Mexico Legal Cannabis Companies
CHAPTER 8- EUROPE LEGAL CANNABIS MARKET SIZE ANALYSIS AND OUTLOOK
8.1. Europe Legal Cannabis Market Overview, 2026
8.2. Leading Companies Operating in Europe
8.3. Key Industry Statistics, 2026
8.4. Europe Legal Cannabis Market Trends and Growth Opportunities to 2034
8.5. Europe Legal Cannabis Market Size Outlook by Type
8.6. Europe Legal Cannabis Market Size Outlook by Application
8.7. Europe Legal Cannabis Market Size Outlook by Country
8.8. Germany
8.8.1. Key Statistics
8.8.2. Germany Legal Cannabis Market Size Outlook, 2021- 2034
8.8.3. Key Market Drivers and Industry Developments in Germany Legal Cannabis Companies
8.9. France
8.9.1. Key Statistics
8.9.2. France Legal Cannabis Market Size Outlook, 2021- 2034
8.9.3. Key Market Drivers and Industry Developments in France Legal Cannabis Companies
8.10. United Kingdom
8.10.1. Key Statistics
8.10.2. United Kingdom Legal Cannabis Market Size Outlook, 2021- 2034
8.10.3. Key Market Drivers and Industry Developments in the UK Legal Cannabis Companies
8.11. Spain
8.11.1. Key Statistics
8.11.2. Spain Legal Cannabis Market Size Outlook, 2021- 2034
8.11.3. Key Market Drivers and Industry Developments in Spain Legal Cannabis Companies
8.12. Italy
8.12.1. Key Statistics
8.12.2. Italy Legal Cannabis Market Size Outlook, 2021- 2034
8.12.3. Key Market Drivers and Industry Developments in Italy Legal Cannabis Companies
8.13. Rest of Europe
8.13.1. Key Statistics
8.13.2. Rest of Europe Legal Cannabis Market Size Outlook, 2021- 2034
8.13.3. Key Market Drivers and Industry Developments in Rest of Europe Legal Cannabis Companies
CHAPTER 9- ASIA PACIFIC LEGAL CANNABIS MARKET SIZE ANALYSIS AND OUTLOOK
9.1. Asia Pacific Legal Cannabis Market Overview, 2026
9.2. Leading Companies Operating in Asia Pacific
9.3. Key Industry Statistics, 2026
9.4. Asia Pacific Legal Cannabis Market Trends and Growth Opportunities to 2034
9.5. Asia Pacific Legal Cannabis Market Size Outlook by Type
9.6. Asia Pacific Legal Cannabis Market Size Outlook by Application
9.7. Asia Pacific Legal Cannabis Market Size Outlook by Country
9.8. China
9.8.1. Key Statistics
9.8.2. China Legal Cannabis Market Size Outlook, 2021- 2034
9.8.3. Key Market Drivers and Industry Developments in China Legal Cannabis Companies
9.9. Japan
9.9.1. Key Statistics
9.9.2. Japan Legal Cannabis Market Size Outlook, 2021- 2034
9.9.3. Key Market Drivers and Industry Developments in Japan Legal Cannabis Companies
9.10. India
9.10.1. Key Statistics
9.10.2. India Legal Cannabis Market Size Outlook, 2021- 2034
9.10.3. Key Market Drivers and Industry Developments in India Legal Cannabis Companies
9.11. South Korea
9.11.1. Key Statistics
9.11.2. South Korea Legal Cannabis Market Size Outlook, 2021- 2034
9.11.3. Key Market Drivers and Industry Developments in South Korea Legal Cannabis Companies
9.12. Australia
9.12.1. Key Statistics
9.12.2. Australia Legal Cannabis Market Size Outlook, 2021- 2034
9.12.3. Key Market Drivers and Industry Developments in Australia Legal Cannabis Companies
9.13. Southeast Asia
9.13.1. Key Statistics
9.13.2. Southeast Asia Legal Cannabis Market Size Outlook, 2021- 2034
9.13.3. Key Market Drivers and Industry Developments in Southeast Asia Legal Cannabis Companies
CHAPTER 10- SOUTH AND CENTRAL AMERICA LEGAL CANNABIS MARKET SIZE ANALYSIS AND OUTLOOK
10.1. South and Central America Legal Cannabis Market Overview, 2026
10.2. Leading Companies Operating in South and Central America
10.3. Key Industry Statistics, 2026
10.4. South and Central America Legal Cannabis Market Trends and Growth Opportunities to 2034
10.5. South and Central America Legal Cannabis Market Size Outlook by Type
10.6. South and Central America Legal Cannabis Market Size Outlook by Application
10.7. South and Central America Legal Cannabis Market Size Outlook by Country
10.8. Brazil
10.8.1. Key Statistics
10.8.2. Brazil Legal Cannabis Market Size Outlook, 2021- 2034
10.8.3. Key Market Drivers and Industry Developments in Brazil Legal Cannabis Companies
10.9. Argentina
10.9.1. Key Statistics
10.9.2. Argentina Legal Cannabis Market Size Outlook, 2021- 2034
10.9.3. Key Market Drivers and Industry Developments in Argentina Legal Cannabis Companies
10.10. Rest of Latin America
10.10.1. Key Statistics
10.10.2. Rest of Latin America Legal Cannabis Market Size Outlook, 2021- 2034
10.10.3. Key Market Drivers and Industry Developments in Rest of Latin America Legal Cannabis Companies
CHAPTER 11- MIDDLE EAST AND AFRICA LEGAL CANNABIS MARKET SIZE ANALYSIS AND OUTLOOK
11.1. Middle East and Africa Legal Cannabis Market Overview, 2026
11.2. Leading Companies Operating in Middle East and Africa
11.3. Key Industry Statistics, 2026
11.4. Middle East and Africa Legal Cannabis Market Trends and Growth Opportunities to 2034
11.5. Middle East and Africa Legal Cannabis Market Size Outlook by Type
11.6. Middle East and Africa Legal Cannabis Market Size Outlook by Application
11.7. Middle East and Africa Legal Cannabis Market Size Outlook by Country
11.8. Saudi Arabia
11.8.1. Key Statistics
11.8.2. Saudi Arabia Legal Cannabis Market Size Outlook, 2021- 2034
11.8.3. Key Market Drivers and Industry Developments in Saudi Arabia Legal Cannabis Companies
11.9. United Arab Emirates
11.9.1. Key Statistics
11.9.2. The UAE Legal Cannabis Market Size Outlook, 2021- 2034
11.9.3. Key Market Drivers and Industry Developments in the UAE Legal Cannabis Companies
11.10. Africa
11.10.1. Key Statistics
11.10.2. Africa Legal Cannabis Market Size Outlook, 2021- 2034
11.10.3. Key Market Drivers and Industry Developments in Africa Legal Cannabis Companies
CHAPTER 12- COMPANY PROFILES
12.1. Top Companies in Legal Cannabis Industry
Curaleaf Holdings, Inc.
Green Thumb Industries (GTI)
Trulieve Cannabis Corp.
Cresco Labs Inc.
Tilray Brands, Inc.
Canopy Growth Corporation
Aurora Cannabis Inc.
Verano Holdings Corp.
Cronos Group Inc.
Jazz Pharmaceuticals plc (GW Pharmaceuticals portfolio)
12.2. Business Description
12.3. SWOT Profiles
12.4. Products and Services
CHAPTER 13- APPENDIX
Glossary of Terms
Research Methodology & Data Sources
Conclusion & Strategic Recommendations
